Literature DB >> 22547139

Microduplications disrupting the MYT1L gene (2p25.3) are associated with schizophrenia.

Yohan Lee1, Anand Mattai, Robert Long, Judith L Rapoport, Nitin Gogtay, Anjené M Addington.   

Abstract

Childhood-onset schizophrenia (COS) is a rare severe form of schizophrenia that may have greater salient genetic risk. Despite evidence for high heritability, conclusive genetic causes of schizophrenia remain elusive. Recent genomic technologies in concert with large case-control cohorts have led to several associations of highly penetrant rare copy number variants (CNVs) and schizophrenia. We previously reported two patients with COS who carried a microduplication disrupting the PXDN and MYT1L genes at 2p25.3. This rate of duplications within our COS population (N=92) is significantly higher than that in 2026 healthy controls (P=0.002). As a replication, we report a meta-analysis of four recently published studies that together provide strong evidence for an association between variably sized microduplications involving the MYT1L gene and schizophrenia. None have reported this separately. Altogether, among 5325 patients and 9279 controls, 10 microduplications were observed: nine in patients and one in a control (odds ratio=15.7, P=0.001). Further, the 2% rate observed in our COS patients is also significantly higher than the rate in adult-onset cases (0.14%, odds ratio=16.6, P=0.01). This report adds to the growing body of literature implicating rare CNVs as risk factors for schizophrenia and shows that some risk CNVs are more common among extreme early-onset cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547139      PMCID: PMC3384746          DOI: 10.1097/YPG.0b013e328353ae3d

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  23 in total

1.  Support for the involvement of large copy number variants in the pathogenesis of schizophrenia.

Authors:  George Kirov; Detelina Grozeva; Nadine Norton; Dobril Ivanov; Kiran K Mantripragada; Peter Holmans; Nick Craddock; Michael J Owen; Michael C O'Donovan
Journal:  Hum Mol Genet       Date:  2009-01-29       Impact factor: 6.150

2.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.

Authors:  Tamim H Shaikh; Xiaowu Gai; Juan C Perin; Joseph T Glessner; Hongbo Xie; Kevin Murphy; Ryan O'Hara; Tracy Casalunovo; Laura K Conlin; Monica D'Arcy; Edward C Frackelton; Elizabeth A Geiger; Chad Haldeman-Englert; Marcin Imielinski; Cecilia E Kim; Livija Medne; Kiran Annaiah; Jonathan P Bradfield; Elvira Dabaghyan; Andrew Eckert; Chioma C Onyiah; Svetlana Ostapenko; F George Otieno; Erin Santa; Julie L Shaner; Robert Skraban; Ryan M Smith; Josephine Elia; Elizabeth Goldmuntz; Nancy B Spinner; Elaine H Zackai; Rosetta M Chiavacci; Robert Grundmeier; Eric F Rappaport; Struan F A Grant; Peter S White; Hakon Hakonarson
Journal:  Genome Res       Date:  2009-07-10       Impact factor: 9.043

Review 3.  The role of copy number variation in schizophrenia.

Authors:  George Kirov
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 4.  Evolution in health and medicine Sackler colloquium: Genomic disorders: a window into human gene and genome evolution.

Authors:  Claudia M B Carvalho; Feng Zhang; James R Lupski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

Review 5.  Schizophrenia, "just the facts" 4. Clinical features and conceptualization.

Authors:  Rajiv Tandon; Henry A Nasrallah; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2009-03-27       Impact factor: 4.939

6.  Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications.

Authors:  Douglas F Levinson; Jubao Duan; Sang Oh; Kai Wang; Alan R Sanders; Jianxin Shi; Nancy Zhang; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Kenneth S Kendler; Robert Freedman; Frank Dudbridge; Itsik Pe'er; Hakon Hakonarson; Sarah E Bergen; Ayman H Fanous; Peter A Holmans; Pablo V Gejman
Journal:  Am J Psychiatry       Date:  2011-02-01       Impact factor: 18.112

7.  New copy number variations in schizophrenia.

Authors:  Chiara Magri; Emilio Sacchetti; Michele Traversa; Paolo Valsecchi; Rita Gardella; Cristian Bonvicini; Alessandra Minelli; Massimo Gennarelli; Sergio Barlati
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

8.  Direct conversion of fibroblasts to functional neurons by defined factors.

Authors:  Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2010-01-27       Impact factor: 49.962

9.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

10.  Copy number variations of chromosome 16p13.1 region associated with schizophrenia.

Authors:  A Ingason; D Rujescu; S Cichon; E Sigurdsson; T Sigmundsson; O P H Pietiläinen; J E Buizer-Voskamp; E Strengman; C Francks; P Muglia; A Gylfason; O Gustafsson; P I Olason; S Steinberg; T Hansen; K D Jakobsen; H B Rasmussen; I Giegling; H-J Möller; A Hartmann; C Crombie; G Fraser; N Walker; J Lonnqvist; J Suvisaari; A Tuulio-Henriksson; E Bramon; L A Kiemeney; B Franke; R Murray; E Vassos; T Toulopoulou; T W Mühleisen; S Tosato; M Ruggeri; S Djurovic; O A Andreassen; Z Zhang; T Werge; R A Ophoff; M Rietschel; M M Nöthen; H Petursson; H Stefansson; L Peltonen; D Collier; K Stefansson; D M St Clair
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

View more
  27 in total

1.  Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18, and MYT1L genes.

Authors:  Martine Doco-Fenzy; Camille Leroy; Anouck Schneider; Florence Petit; Marie-Ange Delrue; Joris Andrieux; Laurence Perrin-Sabourin; Emilie Landais; Azzedine Aboura; Jacques Puechberty; Manon Girard; Magali Tournaire; Elodie Sanchez; Caroline Rooryck; Agnès Ameil; Michel Goossens; Philippe Jonveaux; Geneviève Lefort; Laurence Taine; Dorothée Cailley; Dominique Gaillard; Bruno Leheup; Pierre Sarda; David Geneviève
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

2.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

Review 3.  Distribution of disease-associated copy number variants across distinct disorders of cognitive development.

Authors:  Matthew F Pescosolido; Ece D Gamsiz; Shailender Nagpal; Eric M Morrow
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-04       Impact factor: 8.829

4.  Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions.

Authors:  Makoto Kinoshita; Shusuke Numata; Atsushi Tajima; Kazutaka Ohi; Ryota Hashimoto; Shinji Shimodera; Issei Imoto; Masatoshi Takeda; Tetsuro Ohmori
Journal:  Neuromolecular Med       Date:  2014-07-23       Impact factor: 3.843

5.  Genomic structural variants are linked with intellectual disability.

Authors:  Kazima Bulayeva; Klaus-Peter Lesch; Oleg Bulayev; Christopher Walsh; Stephen Glatt; Farida Gurgenova; Jamilja Omarova; Irina Berdichevets; Paul M Thompson
Journal:  J Neural Transm (Vienna)       Date:  2015-01-28       Impact factor: 3.575

6.  Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.

Authors:  Yanqing Shi; Qi Shao; Zhenghao Li; Ginez A Gonzalez; Fengfeng Lu; Dan Wang; Yingyan Pu; Aijun Huang; Chao Zhao; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2018-02-03       Impact factor: 5.203

7.  Novel mutations in PXDN cause microphthalmia and anterior segment dysgenesis.

Authors:  Alex Choi; Richard Lao; Paul Ling-Fung Tang; Eunice Wan; Wasima Mayer; Tanya Bardakjian; Gary M Shaw; Pui-Yan Kwok; Adele Schneider; Anne Slavotinek
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

Review 8.  Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder.

Authors:  Brent R Bill; Jennifer K Lowe; Christina T Dybuncio; Brent L Fogel
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

9.  High rate of disease-related copy number variations in childhood onset schizophrenia.

Authors:  K Ahn; N Gotay; T M Andersen; A A Anvari; P Gochman; Y Lee; S Sanders; S Guha; A Darvasi; J T Glessner; H Hakonarson; T Lencz; M W State; Y Y Shugart; J L Rapoport
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

10.  MYT1L: A systematic review of genetic variation encompassing schizophrenia and autism.

Authors:  Patricia Mansfield; John N Constantino; Dustin Baldridge
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-04-08       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.